FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Watson Laboratories Zovia Recall

Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tabl…

Watson Laboratories Inc · Corona, CA

Risk level
Class II
Reported by FDA
Oct 31, 2012
Recall ID
D-013-2013
Check your lot numberHow we source this data

Summary

Watson Laboratories recalled Zovia starting Oct 19, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-013-2013 on Oct 31, 2012. Reason: Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ). Status: Terminated.

Why it was recalled

Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).

Product description

Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson Pharma, Inc.; NDC 52544-383-28.

Lot numbers, UPCs & expiration codes

Lot #: 515622AA, 515623AA, and 515623BA, Exp 09/30/13

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-013-2013
Classification
Class II
Status
Terminated
Recall initiated
Oct 19, 2012
FDA report date
Oct 31, 2012
Quantity
30,267 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Watson Laboratories Inc

Original FDA data

Every field from FDA enforcement report D-013-2013, exactly as published.

Show all FDA fields
City
Corona
State
CA
Status
Terminated
Country
United States
Event ID
63509
Address
311 Bonnie Cir
Code information
Lot #: 515622AA, 515623AA, and 515623BA, Exp 09/30/13
Postal code
92880-2882
Report date
Oct 31, 2012
Product type
Drugs
Recall number
D-013-2013
Classification
Class II
Recalling firm
Watson Laboratories Inc
Product quantity
30,267 cartons
Termination date
Nov 21, 2013
Reason for recall
Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson Pharma, Inc.; NDC 52544-383-28.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Oct 19, 2012
Initial firm notification
Letter
Center classification date
Oct 24, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-013-2013, published Oct 31, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls